Reliance, Inc. (RS) Stock Price & Analysis
Reliance, Inc. (RS) closed at USD 417.92 on Thursday, October 22, 2026, down 0.75% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 421.07; the Oct 22, 2026 session ranged USD 411.34–435 on volume of 510,176 shares. Market capitalization is $21.34B, with a 52-week range of USD 260.31–435 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RS.md
Key facts (RS)
- Last four reported quarters (through Jun 30, 2026): revenue $15.8B, net income $894M (5.7% margin), free cash flow $540M (SEC filings).
- Valuation: P/E 23.9x (avg 16.8x at the last 3 fiscal year-ends), EV/EBITDA 15.0x, net debt $1.43B.
- 2 of 80 tracked superinvestors hold RS (13F, Q2 2026): 0 new, 2 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (9 analysts), mean target USD 420.33 (range 400–435).
- Total return with dividends: 1Y +55.0% vs S&P 500 +14.9%; 5Y +203.1% vs S&P 500 +80.3%.
- Next earnings: 2026-10-21, EPS estimate USD 6.62, revenue estimate $4.98B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (RS)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $14.1B | $17.0B | $14.8B | $13.8B | $14.3B | $15.8B |
| Operating income | $1.95B | $2.51B | $1.74B | $1.16B | $1.01B | $1.24B |
| Net income | $1.42B | $1.84B | $1.34B | $875M | $739M | $894M |
| EPS (diluted) | $21.97 | $29.92 | $22.64 | $15.56 | $13.98 | — |
| Free cash flow | $563M | $1.78B | $1.20B | $999M | $503M | $540M |
| Operating margin | 13.8% | 14.7% | 11.7% | 8.4% | 7.1% | 7.8% |
| Net margin | 10.1% | 10.8% | 9.0% | 6.3% | 5.2% | 5.7% |
| Revenue growth | +59.9% | +20.8% | -13.0% | -6.6% | +3.3% | — |
| Cash + short-term investments | $301M | $1.17B | $1.08B | $318M | $217M | — |
| Total debt | $1.66B | $1.66B | $1.15B | $1.14B | $1.42B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (RS)
P/E 23.9x · P/S 1.4x · EV/EBITDA 15.0x · EV/Sales 1.4x · P/FCF 39.5x · P/B 2.9x · FCF yield 2.53% · Earnings yield 4.19% · Buyback yield (TTM) 2.32% · Net debt $1.43B · EV $22.8B
P/E at fiscal year-ends: Dec 2025 20.7x, Dec 2024 17.3x, Dec 2023 12.4x.
Superinvestors (SEC 13F-HR, Q2 2026) (RS)
2 of 80 tracked investors hold RS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Yacktman Asset Management | 3.23% | $261M | Added +0.8% | |
| First Eagle Investment | First Eagle Investment Management | <0.01% | $545K | Added +35.8% |
Analysts (RS)
Consensus Hold (mean 3.00 on a 1–5 scale), 9 analysts; mean target USD 420.33 (low 400, high 435).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Wells Fargo | Target raised | Equal-Weight | $391 → $420 |
| 2026-10-14 | Barclays | Initiated | Equal-Weight | $420 |
| 2026-10-09 | JP Morgan | Target raised | Neutral | $390 → $400 |
| 2026-10-05 | Keybanc | Target raised | Overweight | $418 → $421 |
| 2026-09-09 | JP Morgan | Target lowered | Neutral | $398 → $390 |
| 2026-08-24 | Wells Fargo | Target lowered | Equal-Weight | $398 → $391 |
| 2026-07-27 | BMO Capital | Target raised | Market Perform | $390 → $415 |
| 2026-07-23 | Wells Fargo | Target raised | Equal-Weight | $372 → $398 |
| 2026-07-15 | JP Morgan | Target lowered | Neutral | $378 → $376 |
| 2026-07-09 | Wells Fargo | Target lowered | Equal-Weight | $376 → $372 |
Total return (dividends reinvested) (RS)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +55.0% | +203.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +55.2% | +24.8% |
| Volatility (annualized) | 24.7% | 27.1% |
| Max drawdown | -19.1% (Feb 2026→Mar 2026) | -20.9% (Apr 2024→Mar 2025) |
RS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $6.62 | $4.73 | +40.1% | $4.98B | 7 |
| Next quarter (ends Mar 2027) | $6.62 | $5.39 | +22.8% | $4.53B | 4 |
| Current fiscal year (ends Dec 2026) | $25.13 | $22.32 | +12.6% | $18.85B | 7 |
| Next fiscal year (ends Dec 2027) | $24.87 | $21.83 | +13.9% | $17.97B | 9 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 417.92 |
|---|---|
| Change | ▼ 0.75% (down) |
| Previous Close | USD 421.07 |
| Open | USD 426.97 |
| Day Range | USD 411.34 – 435 |
| 52-Week Range | USD 260.31 – 435 |
| Volume | 510,176 shares |
| Market Cap | $21.34B |
| Exchange | NYQ |
Technical Analysis (RS)
Nexqual's technical model rates RS "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.68 (neutral) |
| vs SMA50 | Above (USD 398.26) |
| MACD | 6.16 (positive) |
Analyst Ratings (RS)
Wall Street analysts rate RS "Hold" based on 9 analysts, with a mean price target of USD 420.33 (range USD 400–435), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 420.33 |
| High Target | USD 435 |
| Low Target | USD 400 |
| Buy / Hold / Sell | 2 / 6 / 1 |
Earnings (RS)
| Next Earnings Date | 2026-10-21 |
|---|---|
| EPS Estimate | USD 6.62 |
| Revenue Estimate | $4.98B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 8.02 vs est 6.83 ▲ beat |
| 2026-06-30 | USD 6.27 vs est 5.47 ▲ beat |
| 2026-03-31 | USD 5.16 vs est 4.66 ▲ beat |
| 2025-12-31 | USD 2.4 vs est 2.82 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (RS)
| Total Revenue | $15.81B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +26.50% |
| Gross Margin | +28.29% |
| Operating Margin | +9.54% |
| Profit Margin | +5.66% |
| ROE | +12.23% |
| Debt / Equity | 0.27 |
| Current Ratio | 4.3 |
| Total Cash | $235.40M |
| Total Debt | $2.00B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $539.50M (3.4% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (RS)
Nexqual rates Reliance, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Mixed — Revenue +3.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 28%, operating 10% (last 12 months) |
| Balance Sheet | Strong — $235M cash and investments vs $1.66B debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $540M (last 4 quarters to Jun 2026, SEC), slim 3.4% margin |
| Efficiency | Mixed — ROE 12%, ROA 7.3% |
Ownership (RS)
| Insider Ownership | +0.46% |
|---|---|
| Institutional Ownership | +84.56% |
| Shares Outstanding | 51.05M |
| Float | 50.80M |
| Short % of Float | +3.36% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (RS)
Reliance, Inc. is led by Karla R. Lewis, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| President, CEO & Director | Karla R. Lewis |
|---|---|
| CFO & Senior VP | Arthur Ajemyan |
| Executive VP & COO | Stephen P. Koch |
| Senior Vice President of Strategic Planning & Programs | Brenda S. Miyamoto CMT |
Major Backers & Investors (RS)
Notable institutional backers of Reliance, Inc. include Boston Partners, Price (T.Rowe) Associates Inc, Wellington Management, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Boston Partners | 4.3% |
| Price (T.Rowe) Associates Inc | 3.02% |
| Wellington Management | 2.61% |
| Franklin Resources, Inc. | 1.63% |
| Alliancebernstein L.P. | 1.42% |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.42% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 11.38% |
| Vanguard Group | 10.96% |
| State Street | 5.14% |
| Geode Capital | 1.87% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PKX | POSCO Holdings Inc. | USD 52.35 | ▼ 6.27% |
| STLD | Steel Dynamics, Inc. | USD 239.9 | ▼ 3.25% |
| TX | Ternium S.A. Ternium S.A. | USD 55.36 | ▼ 6.04% |
| MT | Arcelor Mittal NY Registry Shar | USD 60.18 | ▼ 5.18% |
| GGB | Gerdau S.A. | USD 5.07 | ▼ 3.24% |
| NUE | Nucor Corporation | USD 258.06 | ▼ 2.45% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt